Evaluation of Drug Management Systems at Talaud District Hospital Pharmacy: A Qualitative Approach

Gayatri Citraningtyas1*, Heri Wijaya2

1Department of Pharmacy, Universitas Sam Ratulangi, Kota Manado, Sulawesi Utara 95115, Indonesia

2Sekolah Tinggi Ilmu Kesehatan Samarinda, Kota Samarinda, Kalimantan Timur 75124, Indonesia

*Corresponding Author’s Email: gayatricitra88@gmail.com

Abstract

Background: Drug management in hospitals is a crucial component to ensure the availability, quality, and efficiency of pharmaceutical services. The aim of this study is to evaluate the drug management process in the Pharmacy Installation of Talaud Hospital based on the Ministry of Health Regulation No. 72 of 2016. Methods: This qualitative descriptive study was conducted in May–June 2025 using purposive sampling. Data were collected through interviews and observations. Interview guides and checklists were developed based on the national pharmaceutical service standards. Results: The drug selection was aligned with the hospital formulary. Planning was conducted using consumption methods, while procurement was based on e-catalogue with proper documentation. Drug storage adhered to FIFO and FEFO principles, but limited space and human resources were identified. Distribution for outpatient used an individual prescription system and inpatient used Unit Dose Dispensing (UDD). Documentation and reporting were still manual. Evaluation activities were conducted annually without specific analysis. Conclusion: The drug management system at Talaud Hospital generally complies with the Ministry of Health standards. However, improvements are needed in procurement timelines, staffing for clinical pharmacy services, digital documentation, and comprehensive evaluations.

Keywords: Drug Management, Hospital Pharmacy, Talaud Hospital

Introduction

Pharmaceutical services in hospitals are critical to ensuring safe, effective, and rational use of medicines, which ultimately contributes to improved patient outcomes, reduced medication errors, and optimised resource utilisation (WHO, 2019). Hospital pharmacies are not merely centers for drug dispensing, but strategic units responsible for the comprehensive management of medicines, including selection, procurement, storage, distribution, monitoring, and evaluation (FIP, 2022). As the scope of clinical pharmacy practice expands globally, the quality of drug management systems has become a benchmark for assessing hospital performance and health system resilience (Alomi, 2015, Ahmed & Tamim, 2025). In low- and middle-income countries (LMICs), particularly in remote and archipelagic regions, numerous challenges hinder effective pharmaceutical management. These include limited access to essential medicines, poor infrastructure, manual documentation systems, inconsistent procurement cycles, and a shortage of trained pharmacists (Ofori-Asenso & Agyeman, 2016). A well- functioning drug supply system must balance the needs of safety, timeliness, cost-efficiency, and therapeutic effectiveness (Yadav, 2015). Failure to meet these standards not only affects patient care but also disrupts supply chain integrity, resulting in frequent stockouts, overstocking, or expired medications.

The WHO advocates for the implementation of Good Pharmacy Practices (GPP), emphasising the need for standardised documentation, digital systems integration, and continuous performance evaluations (WHO, 2019). Tools such as ABC-VEN analysis, Economic Order Quantity (EOQ), and inventory turnover ratios are widely used in hospital settings to monitor and optimise stock levels (Peter, 2023). Moreover, the integration of Hospital Information Systems (HIS) has been shown to significantly reduce medication errors, improve transparency, and streamline procurement processes (Epizitone et al., 2023; Prayuda et al., 2021). In the context of Eastern Indonesia, particularly small island regions, health facilities often face compounded challenges due to geographical isolation. Preliminary assessments at Talaud District Hospital identified ongoing issues such as manual documentation, irregular procurement timelines, limited pharmacist involvement in clinical care, and minimal application of analytical tools in inventory management. These conditions highlight the urgent need to evaluate the hospital's drug management practices in accordance with international standards to ensure sustainable and safe pharmaceutical care. Therefore, this study aims to conduct a qualitative evaluation of drug management practices at the Pharmacy Installation of Talaud District Hospital, focusing on alignment with WHO guidelines and global hospital pharmacy standards. The findings are expected to inform improvements in logistics, human resources, and service quality within similar rural hospital contexts.

Methodology

This is a descriptive qualitative study conducted at the Pharmacy Installation of Talaud District Hospital from May to June 2025. The study employed purposive sampling, involving key informants including pharmacy heads, procurement staff, and warehouse personnel. Data collection involved structured interviews and direct observation using checklists adapted from the Ministry of Health guidelines. Data were analysed using thematic content analysis to identify patterns and categorise findings according to the main components of drug management.

Results

Drug management in hospitals begins with the stages of selection, planning, procurement, receiving, storage, distribution, recall and destruction, control, recording and reporting, as well as evaluation. The following is the observation result related to drug management at Talaud District Hospital.

Table 1: Observation Results of Drug Management at Talaud District Hospital Pharmacy Installation


Observation Variable

Yes

No

Remarks

KFT team available

Hospital formulary available

Treatment/therapy standards available

Using hospital formulary

Determination of drug types and quantities to be ordered

Request report from Pharmacy to Planning Department

Done by the Pharmacy warehouse department

Availability of documents on drug selection and planning

Procurement and Receiving Variables

Drug procurement based on purchase order (PO)

Uses e-catalogue system (not direct order)

Receipt of drug donations/grants

From Provincial Health Office 2024, Ministry of BMHP 2022

Procurement considers minimum 2-year expiration date

Dedicated shelf for PO and invoice document storage

Archive shelf for returned goods

Stored together with other archived items

Monitoring of order status to avoid delays

Handled by Procurement section

Availability of COA for raw materials and MSDS for hazardous items

Not yet available / not yet implemented

Pharmaceuticals for research purposes

Not yet available / never conducted

Availability of handover documentation

Storage Variables

Drugs and chemicals labeled with name, date of opening, expiry date, special warnings

High-concentration electrolytes not stored in patient care units unless urgent

Electrolytes in care units labeled, secured, stored in restricted areas

Patient’s personal medicines, devices stored separately and identifiable

Drug storage areas not used for other items that may cause contamination

Flammable items stored in fireproof rooms and labeled as hazardous

Medical gas stored upright, secured, labeled as hazardous

Not stored in main pharmacy warehouse but in a separate, monitored area

Empty gas cylinders stored separately from filled ones

Gas cylinders stored with safety caps

Cylinders taken only when needed

Drugs, medical devices stored separately, arranged alphabetically

Implementation of FIFO principle

Implementation of FEFO principle

Storage based on therapeutic class, dosage form, type

Currently based only on dosage form

LASA items not stored together, clearly marked

Emergency drugs stored in a designated area

Emergency drug storage easily accessible and secure

Warehouse space adequate and safe for staff movement

Space is limited, but storage is secure

Warehouse has proper sanitation

Adequate lighting in warehouse

Drug storage area separate from service areas

Roof and walls in good condition, no leakage

Clean floors with pallets

Adequate ventilation and air circulation

Free from pests and animals

Clean storage racks/cabinets available

Special cabinet for specific drugs

Refrigeration units for specific drugs available

Two refrigerators available

Equipment for moving medicines available

Drugs arranged using FIFO and FEFO principles

Restricted access to drug storage areas

Fire extinguishers available near storage

Temperature/humidity measuring tools available

Air conditioners/cooling in storage area

Documented records on drug storage

Stock cards available

Control Variables

The use of drugs according to the RS formulary

Use of medication according to diagnosis and therapy

There is a special shelf for damaged and expired drugs

Di ruangan sendiri

Officers check ED drugs, damaged periodically

There is a special shelf for medicines slow moving/ death stock

There is documentary evidence

Distribution Variables

Floor stock system

Drug distribution for inpatient stock managed by Pharmacy

Inpatient stock matches required types and quantities

If no pharmacy staff after working hours, responsibility delegated to ward officer

Pharmacy service is available 24/7

Drug handover from ward officer to pharmacist

Not yet implemented

Pharmacist provides information, warnings, interactions for each drug in floor stock

Directly monitored by pharmacy; clinical pharmacy not yet implemented

Distribution based on outpatient/inpatient prescription via Pharmacy

For inpatient, drugs collected by patient/family/nurse?

Patient's family

Individual prescription prepared as single/double unit dose for inpatients

Record of outbound goods from warehouse

Destruction and Recall Variables

Preparation of drug destruction list

Preparation of drug destruction report

Coordination of schedule, method, and site for destruction

Preparation of destruction site

Destruction according to dosage form and applicable regulations

Drug recall conducted by BPOM or original manufacturer

Record of recall activities available

Recording and Reporting Variables

Recording for:

  1. Ministry of Health/BPOM requirements,

  2. accreditation,

  3. hospital audit,

  4. pharmaceutical

  5. documentation,

  6. etc.

Designated staff for recording Reporting includes:

  1. annual pharmacy activities,

  2. financial reports,

  3. etc.

Designated staff for reporting

Dedicated archive cabinet available

Discussion

Based on the observations, the selection of pharmaceutical supplies at Talaud District Hospital was based on the hospital formulary, making drug planning more efficient. The hospital formulary, which aligns with the National Formulary, supports rational drug use by increasing access to essential medicines. To promote compliance and rationality, the hospital formulary should be formulated based on therapeutic needs, proposed by prescribers, and discussed in the Pharmacy and Therapeutics Committee meetings, considering efficacy, safety, quality, and cost. The finalised formulary should be disseminated to all health workers in both hard-copy and soft-copy formats (FIP, 2022). Drug planning at Talaud Hospital uses the consumption method based on previous periods’ needs, as confirmed by interviews with the Head of the Pharmacy Installation. Planning starts with stock checking by warehouse staff and proceeds through the e-Monev application, which automatically calculates drug requirements. Not all drugs are procured every month; those with sufficient stock are scheduled for future procurement periods. Efficient planning requires considering available inventory. WHO (2022) recommends that planning should avoid stockouts using defensible methods and adjust based on budget, priority, consumption history, lead time, and development plans.

The procurement process is carried out through e-catalogue systems. Drugs are received by a team comprising procurement staff, the head of the pharmacy, and warehouse personnel. Observations showed that items are checked for condition and invoice conformity (Islam, 2024). Expiry dates of at least two years are required unless for special pharmaceutical preparations like vaccines or reagents. Returned items include damaged packages, expired drugs (within 2 months), or items not listed in the purchase order. This approach is consistent with WHO procurement recommendations (WHO, 2019). The pharmacy warehouse is managed by two staff responsible for storage and distribution. Good storage preserves drug quality, improves efficiency, reduces damage/loss, optimises inventory, and informs future procurement. The warehouse, approximately 4x8 m², organises drugs by dosage form and alphabetical order. LASA drugs, high-alert drugs, narcotics, psychotropics, and refrigerated items are stored separately. Flammable materials have a separate room, and gas cylinders are stored outside due to space limitations. The FEFO system is applied, with expiry labels placed on secondary packaging. However, due to limited human resources, administrative staff also organise inventory, necessitating training on proper storage procedures (Peter, 2023, Roy et al., 2025).

The hospital applies a centralised distribution system. There is no pharmacy satellite unit; all pharmaceutical needs are directly supplied by the main Pharmacy Installation. Outpatient distribution uses individual prescribing, while inpatient distribution follows the Unit Dose Dispensing (UDD) model, which sends medications per patient and per administration time. UDD has been shown to improve patient safety and reduce medication waste when supported by effective management (Boag et al., 2021; Dzierba et al., 2020). Emergency trolleys are provided in wards for urgent medical needs. However, the lack of standby pharmacists due to HR limitations means the trolleys are managed by ward nurses. When nurses are overwhelmed, patients' families collect medications. This limits pharmacists’ roles in emergency preparedness and clinical pharmacy. Expired and damaged medicines are destroyed annually with third-party involvement. Recalls are handled by distributors upon BPOM notification. Documentation and coordination are carried out by pharmacy staff and sanitation units. Controlled substances are destroyed in coordination with local health authorities in accordance with laws (WHO, 2023).

Stock-taking is conducted by pharmacy and administrative staff. Tasks include verifying stock records and separating drugs near expiry. Slow-moving drugs are listed and distributed to departments to avoid expiry (Jobira et al., 2021). There were no dead stock items, indicating effective inventory use. All recording and reporting activities are done manually, which is time-consuming. Archive rooms and printed stock cards are used. Monthly reports include prescription volume, service waiting time, and prescription conformity with the formulary. WHO (2022) advocates digitalisation to improve traceability, accuracy, and efficiency. Drug management evaluation is performed annually but lacks depth. Tools like ABC-VEN, EOQ, and turnover analysis are not used. Integrating such tools could enhance planning, control costs, and prevent shortages (Prassetiyo et al., 2023, Soraya et al., 2022).

Conclusion

The drug management process at the Pharmacy Installation of Talaud District Hospital generally complies with the Pharmaceutical Service Standards outlined in Minister of Health Regulation No. 72 of 2016. However, several areas still require improvement. These include delays in drug procurement due to long lead times, the need for specific scheduling of pharmacists in clinical and pharmacy services due to limited human resources, the continued use of manual recording and reporting systems, and the absence of structured evaluations beyond daily operational activities. Enhancing these areas is essential to optimise the overall quality of pharmaceutical services and ensure effective and efficient drug management at the hospital.

Conflict of Interest

The authors affirm that they have no conflicting interests.

Acknowledgement

The authors would like to express their gratitude to all individuals who contributed to this study but did not meet the criteria for authorship. Special thanks to the technical staff at Talaud District Hospital for their assistance during data collection, and to the head of the Pharmacy Installation Department for their general support throughout the research process. The authors also acknowledge the institutional support provided by the Faculty of Mathematics and Natural Sciences, Universitas Sam Ratulangi and Universitas Kristen Indonesia Tomohon. No specific funding was received for this work. The authors declare no financial or material conflicts of interest related to this publication.

References

Ahmed, R., & Tamim, T. R. (2025). Enhancing medication safety: the role of community and hospital pharmacists in modern healthcare systems. Radinka Journal of Health Science, 2(3), 328-355. https://doi.org/10.56778/rjhs.v2i3.418

Alomi, Y. A. (2015). National pharmacy practice programs at ministry of health in Saudi Arabia. Journal of Pharm Pharmaceutical Sciences, 1(2), 17-8. https://doi.org/10.24218/vjpps.2015.10

Boag, L., Maclure, K., Boyter, A., Cunningham, S., Akram, G., Mcquillan, H., & Stewart, D. (2021). Public perceptions and experiences of the minor ailment service in community pharmacy in Scotland. Pharmacy Practice (Granada), 19(1). https://doi.org/10.18549/PharmPract.2021.1.2152

Dzierba, A. L., Pedone, T., Patel, M. K., Ciolek, A., Mehta, M., Berger, K., ... & Witenko, C. J. (2020). Rethinking the Drug Distribution and Medication Management Model: How a New York City Hospital Pharmacy Department Responded to COVID19. Journal of the American College of Clinical Pharmacy, 3(8), 1471-1479. https://doi.org/10.1002/jac5.1316

Epizitone, A., Moyane, S. P., & Agbehadji, I. E. (2023, March). A systematic literature review of health information systems for healthcare. In Healthcare (Vol. 11, No. 7, p. 959). MDPI. https://doi.org/10.3390/healthcare11070959

International Pharmaceutical Federation (FIP), Hospital Pharmacy Section. (2022). Hospital Pharmacy Section Strategic Plan 2022–2027. The Hague: FIP. Retrieved from https://www.fip.org/files/content/pharmacy-practice/hospital- pharmacy/FIP_HPS_Strategic_Plan_2022-2027.pdf

Islam, M. (2024). Procurement & supply chain management practice in retail pharmacy business: a comprehensive study in context of Wellbeing Pharmacy. http://hdl.handle.net/10361/24903

Jobira, T., Abuye, H., Jemal, A., & Gudeta, T. (2021). Evaluation of pharmaceuticals inventory management in selected health facilities of West Arsi Zone, Oromia, Ethiopia. Integrated Pharmacy Research and Practice, 1-11. https://doi.org/10.2147/IPRP.S298660

Ofori-Asenso, R., & Agyeman, A. A. (2016). Irrational use of medicines—a summary of key concepts. Pharmacy, 4(4), 35. https://doi.org/10.3390/pharmacy4040035

Peter, J. (2023). Assessment of Inventory Management Practices on the Performance of Public Hospital in Mwanza Region (Doctoral dissertation, Institute of Accountancy Arusha (IAA)). http://dspace.iaa.ac.tz:8080/xmlui/handle/123456789/2361

Prassetiyo, H., Berry Bachtiar, L. F., & Rukmi, H. S. (2023). Analyzing the inventory system of medical medicine in type b pharmaceutical installations at regional hospitals using the ABC-VEN analysis and continuous review system methods. International Journal of Scientific Advances, 4(4), 576-

582. https://doi.org/10.51542/ijscia.v4i4.13

Prayuda, R., Warsito, T., & Surwandono. (2021). Problems faced by ASEAN in dealing with transnational drug smuggling in Southeast Asia region. foresight, 23(3), 353- 366. https://doi.org/10.1108/FS-12-2019-0106

Roy, A., Kumar, A., Srivastava, A. K., Ansari, F., Kumar, K., Vishwakarma, M., ... & Mahto, I. K. (2025). Disparities in Access to Essential Medicines in India: A Systematic Review of Availability, Affordability and Policy Challenges. International Journal of Scientific Research and Technology. https://doi.org/10.5281/zenodo.15345689

Soraya, C., Surwanti, A., & Pribadi, F. (2022). Drug Inventory Management Using ABC-VEN and EOQ Analysis for Improving Hospital Efficiency. Jurnal Aisyah: Jurnal Ilmu Kesehatan, 7(1), 373-382. https://doi.org/10.30604/jika.v7i1.1319

World Health Organization (WHO). (2019).֦ TRS 1019 - 53rd report of the WHO Expert Committee on Specifications for Pharmaceutical Preparations. https://www.who.int/publications/i/item/WHO_TRS_1019

World Health Organization (WHO). (2022). Health products policy and standards. https://www.who.int/teams/health-product-and-policy-standards/standards-and-specifications/norms- and-standards-for-pharmaceuticals/guidelines/distribution

World Health Organization. (2022). Digital transformation handbook for health supply chain architecture. https://iris.who.int/bitstream/handle/10665/379506/9789240101197-eng.pdf

World Health Organization. (2023). Guidelines for the safe disposal of unwanted pharmaceuticals in and after emergencies. https://iris.who.int/bitstream/handle/10665/42238/WHO_EDM_PAR_99.2.pdf

Yadav, P. (2015). Health product supply chains in developing countries: diagnosis of the root causes of underperformance and an agenda for reform. Health systems & reform, 1(2), 142- 154. https://doi.org/10.4161/23288604.2014.968005